IFITM3P7

Across TCGA pan-cancer cohorts, IFITM3P7 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated IFITM3P7 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher IFITM3P7 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated IFITM3P7 expression acts as an unfavorable survival marker, although some lineages such as PAAD and READ show a favorable association.

ACC, UVM, and PAAD are the cancer types where IFITM3P7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	All	0.135	0.727	<.001	48	view →
UVM	OS	Quartile	All	0.248	0.654	.001	45	view →
PAAD	OS	Tertile	II,III,IV	0.724	0.536	.008	42	view →
LIHC	OS	Quartile	III,IV	0.298	0.598	.001	38	view →
READ	DFS	Median	III,IV	0.913	0.581	.002	33	view →
STAD	DFS	Quartile	II,III,IV	0.507	0.792	.009	32	view →
LUAD	DFS	Quartile	All	0.654	0.821	<.001	31	view →
BRCA	OS	Tertile	IV	0.370	0.711	.009	14	view →
KIRC	DFS	Quartile	All	0.453	0.687	.022	6	view →
KIRP	OS	Quartile	IV	0.166	0.502	.005	6	view →
MESO	OS	Tertile	All	0.647	0.164	.035	6	view →
OV	OS	Quartile	III,IV	0.278	0.398	.025	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

IFITM3P7–ACC (OS)

Open the ACC breakdown →